- Home
- MTNB vs COSM Comparison
MTNB vs COSM Comparison
Compare MTNB & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- COSM
- Stock Information
- Founded
- MTNB 2013
- COSM 2009
- Country
- MTNB United States
- COSM United States
- Employees
- MTNB N/A
- COSM N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- MTNB Health Care
- COSM Health Care
- Exchange
- MTNB Nasdaq
- COSM Nasdaq
- Market Cap
- MTNB 16.1M
- COSM 17.7M
- IPO Year
- MTNB N/A
- COSM 2013
- Fundamental
- Price
- MTNB $0.60
- COSM $0.72
- Analyst Decision
- MTNB Hold
- COSM
- Analyst Count
- MTNB 1
- COSM 0
- Target Price
- MTNB N/A
- COSM N/A
- AVG Volume (30 Days)
- MTNB 578.7K
- COSM 426.2K
- Earning Date
- MTNB 11-13-2024
- COSM 11-14-2024
- Dividend Yield
- MTNB N/A
- COSM N/A
- EPS Growth
- MTNB N/A
- COSM N/A
- EPS
- MTNB N/A
- COSM N/A
- Revenue
- MTNB N/A
- COSM $56,042,109.00
- Revenue This Year
- MTNB N/A
- COSM $7.57
- Revenue Next Year
- MTNB N/A
- COSM $22.58
- P/E Ratio
- MTNB N/A
- COSM N/A
- Revenue Growth
- MTNB N/A
- COSM 13.01
- 52 Week Low
- MTNB $0.50
- COSM $0.47
- 52 Week High
- MTNB $21.50
- COSM $1.65
- Technical
- Relative Strength Index (RSI)
- MTNB 26.12
- COSM 52.95
- Support Level
- MTNB $0.53
- COSM $0.69
- Resistance Level
- MTNB $0.67
- COSM $0.78
- Average True Range (ATR)
- MTNB 0.13
- COSM 0.06
- MACD
- MTNB 0.09
- COSM 0.01
- Stochastic Oscillator
- MTNB 22.41
- COSM 88.24
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.